IP Library Patent Application 13360620
Patent Application
App. No. 13/360,620

GEL-ENCAPSULATED MICROCOLONY SCREENING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/360,620
Filed
Jan 27, 2012
Art Unit
1639
USPC
506/7
Abstract

Provided herein are methods and compositions useful for detecting the production of industrially useful compounds (e.g., isoprenoids, polyketides, and fatty acids) in a cell, for example, a microbial cell genetically modified to produce one or more such compounds. In some embodiments, the methods comprise encapsulating the cell in a hydrogel particle, and detecting the compound within the hydrogel particle.

Claims (69)

1 . A method of detecting recombinantly produced water-immiscible compound in a cell, the method comprising:

(a) encapsulating the cell in a hydrogel particle; and

(b) detecting the recombinantly produced water-immiscible compound within the hydrogel particle.

2 . The method of claim 1 , wherein said detecting comprises contacting the hydrogel particle with a fluorescent dye that directly binds to the recombinantly produced water-immiscible compound and detecting the fluorescent dye within the hydrogel particle.

3 . The method of claim 2 , wherein the fluorescent dye is a solvatochromic dye.

4 . The method of claim 2 , wherein the fluorescent dye is Nile Red.

5 . The method of claim 1 , wherein said detecting comprises normalizing the amount of water-immiscible compound within the hydrogel particle to the amount of biomass within the hydrogel particle.

6 . The method of claim 1 , wherein the cell is selected from the group consisting of a yeast cell, a bacterial cell, a mammalian cell, a fungal cell, an insect cell, and a plant cell.

7 . The method of claim 5 , wherein the cell is a yeast cell.

8 . The method of claim 1 , wherein the recombinantly produced water-immiscible compound is selected from the group consisting of an isoprenoid, a polyketide and a fatty acid.

9 . The method of claim 1 , wherein the hydrogel particle is capable of retaining a water-immiscible compound.

10 . The method of claim 1 , wherein the hydrogel comprises agarose.

11 . The method of claim 1 , wherein the hydrogel particle is less than about 1 millimeter in diameter.

12 . The method of claim 1 , wherein the hydrogel particle is less than about 100 micrometers in diameter.

13 . The method of claim 1 , wherein the hydrogel particle is less than about 50 micrometers in diameter.

14 . The method of claim 1 , wherein the hydrogel particle is about 50, 45, 40, 35, 30, or 25 micrometers in diameter.

15 . The method of claim 1 , wherein said encapsulating comprises contacting the cell with an aqueous hydrogel suspension under conditions sufficient to form a hydrogel particle comprising the cell.

16 . The method of claim 15 , wherein said conditions comprise contacting the aqueous hydrogel suspension comprising the cell with a fluorocarbon oil comprising a fluorosurfactant.

17 . The method of claim 16 , wherein said contacting with a fluorocarbon oil comprises loading the aqueous hydrogel suspension comprising the cell onto a microfluidic device comprising the fluorocarbon oil, wherein said hydrogel suspension contacts the fluorocarbon oil at a T-junction of the microfluidic device, wherein said contacting with the fluorocarbon oil results in formation of a non-aqueous hydrogel particle comprising the cell.

18 . The method of claim 17 , further comprising the step of separating the hydrogel particle from the fluorocarbon oil.

19 . The method of claim 1 , further comprising the step of culturing the cell within the hydrogel particle prior to said detecting.

20 . The method of claim 19 , wherein said culturing is for a period of 12 to 24 hours.

21 . The method of claim 1 , wherein the recombinantly produced water-immiscible compound is a terpene, C 5 isoprenoid, C 10 isoprenoid or C 15 isoprenoid.

22 . The method of claim 21 , wherein the recombinantly produced water-immiscible compound is farnesene.

23 . A method of detecting recombinantly produced water-immiscible compound in a cell, the method comprising:

(a) contacting the cell with an aqueous hydrogel suspension;

(b) loading the aqueous hydrogel suspension comprising the cell onto a microfluidic device comprising a fluorocarbon oil, wherein said hydrogel suspension contacts the fluorocarbon oil at a T-junction of the microfluidic device, wherein said contacting with the fluorocarbon oil results in formation of a non-aqueous hydrogel particle comprising the cell;

(c) separating the hydrogel particle from the fluorocarbon oil;

(d) culturing the cell within the hydrogel particle;

(e) contacting the hydrogel particle with a fluorescent dye that directly binds to the recombinantly produced water-immiscible compound; and

(f) detecting the fluorescent dye within the hydrogel particle.

24 . A method of screening a library of cells for a cell recombinantly producing a water-immiscible compound, the method comprising:

(a) encapsulating each cell of the library in a hydrogel particle;

(b) detecting recombinantly produced water-immiscible compound within each hydrogel particle; and

(c) selecting a cell producing said recombinantly produced water-immiscible compound.

25 . A method of enriching a population of cells for cells recombinantly producing a water-immiscible compound, the method comprising:

(a) providing a population of hydrogel particles, wherein the population comprises hydrogel particles that encapsulate a cell or a clonal population of cells genetically modified to produce a water-immiscible compound;

(b) detecting a hydrogel particle comprising recombinantly produced water-immiscible compound;

(c) recovering the cell or clonal population of cells from the hydrogel particle of step (b);

(d) re-encapsulating the cell or clonal population of cells from step (c); and

(e) repeating steps (a)-(c).

26 . A method of encapsulating a cell within a hydrogel particle, the method comprising:

(a) contacting the cell with an aqueous hydrogel suspension; and

(b) loading the aqueous hydrogel suspension comprising the cell onto a microfluidic device comprising a fluorocarbon oil, wherein said hydrogel suspension contacts the fluorocarbon oil at a T-junction of the microfluidic device, wherein said contacting with the fluorocarbon oil results in formation of a non-aqueous hydrogel particle comprising the cell.

27 . A hydrogel-encapsulated cell or clonal cell population comprising recombinantly produced water-immiscible compound.

28 . The hydrogel-encapsulated cell or clonal cell population of claim 27 contacted with a fluorescent solvatochromic dye.

29 . The hydrogel-encapsulated cell or clonal cell population of claim 27 contacted with Nile Red.

30 . The hydrogel-encapsulated cell or clonal cell population of claim 27 , wherein the cell is selected from the group consisting of a yeast cell, a bacterial cell, a mammalian cell, a fungal cell, an insect cell, and a plant cell.

31 . The hydrogel-encapsulated cell or clonal cell population of claim 27 , wherein the cell is a yeast cell.

32 . The hydrogel-encapsulated cell or clonal cell population of claim 27 , wherein the recombinantly produced water-immiscible compound is selected from the group consisting of an isoprenoid, a polyketide and a fatty acid.

33 . The hydrogel-encapsulated cell or clonal cell population of claim 32 , wherein the recombinantly produced water-immiscible compound is a terpene, C 5 isoprenoid, C 10 isoprenoid or C 15 isoprenoid.

34 . The hydrogel-encapsulated cell or clonal cell population of claim 32 , wherein the recombinantly produced water-immiscible compound is farnesene.

35 . A hydrogel particle comprising a cell or clonal cell population, and further comprising recombinantly produced water-immiscible compound.

36 . The hydrogel particle of claim 35 contacted with a fluorescent solvatochromic dye.

37 . The hydrogel particle of claim 35 contacted with Nile Red.

38 . The hydrogel particle of claim 35 , wherein the cell is selected from the group consisting of a yeast cell, a bacterial cell, a mammalian cell, a fungal cell, an insect cell, and a plant cell.

39 . The hydrogel particle of claim 37 , wherein the cell is a yeast cell.

40 . The hydrogel particle of claim 35 , wherein the recombinantly produced water-immiscible compound is selected from the group consisting of an isoprenoid, a polyketide and a fatty acid.

41 . The hydrogel particle of claim 40 , wherein the isoprenoid is a terpene, C 5 isoprenoid, C 10 isoprenoid or C 15 isoprenoid.

42 . The hydrogel particle of claim 40 , wherein the isoprenoid is farnesene.

43 . The hydrogel particle of claim 42 , wherein the recombinant yeast cell comprises a nucleic acid encoding farnesene synthase.

44 . The hydrogel particle of claim 35 , wherein the hydrogel particle is capable of retaining a water-immiscible compound.

45 . The hydrogel particle of claim 44 , wherein the water-immiscible compound is selected from the group consisting of an isoprenoid, a polyketide and a fatty acid.

46 . The hydrogel particle of claim 44 , wherein the water-immiscible compound is farnesene.

47 . The hydrogel particle of claim 35 , wherein the hydrogel comprises agarose.

48 . The hydrogel particle of claim 35 , wherein the hydrogel particle is less than about 1 millimeter in diameter.

49 . The hydrogel particle of claim 35 , wherein the hydrogel particle is less than about 100 micrometers in diameter.

50 . The hydrogel particle of claim 35 , wherein the hydrogel particle is less than about 50 micrometers in diameter.

51 . The hydrogel particle of claim 35 , wherein the hydrogel particle is about 50, 45, 40, 35, 30, or 25 micrometers in diameter.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Aug 28, 2019
From: STEGODON CORPORATION
To: AMYRIS, INC.
Reel/Frame 050206/0606 →
SECURITY INTEREST Recorded Jun 16, 2016
From: HERCULES CAPITAL INC.
To: STEGODON CORPORATION
Reel/Frame 039048/0251 →
SECURITY INTEREST Recorded Jun 3, 2016
From: AMYRIS, INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 038878/0381 →
RELEASE OF SECURITY INTEREST Recorded Mar 31, 2014
From: MAXWELL (MAURITIUS) PTE LTD
To: AMYRIS, INC.
Reel/Frame 032578/0357 →
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2014
From: TOTAL ENERGIES NOUVELLES ACTIVITES USA, SAS (F/K/A TOTAL GAS & POWER USA, SAS)
To: AMYRIS, INC.
Reel/Frame 032554/0001 →
RELEASE OF SECURITY INTEREST Recorded Mar 27, 2014
From: TOTAL ENERGIES NOUVELLES ACTIVITIES USA, SAS (F/K/A TOTAL GAS & POWER USA, SAS)
To: AMYRIS, INC.
Reel/Frame 032551/0828 →
SECURITY AGREEMENT Recorded Nov 8, 2013
From: AMYRIS, INC.
To: TOTAL ENERGIES NOUVELLES ACTIVITES USA
Reel/Frame 031607/0314 →
SECURITY AGREEMENT Recorded Oct 23, 2013
From: AMYRIS, INC.
To: MAXWELL (MAURITIUS) PTE LTD
Reel/Frame 031478/0933 →
SECURITY AGREEMENT Recorded May 8, 2013
From: AMYRIS, INC.
To: TOTAL GAS & POWER USA, SAS
Reel/Frame 030378/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2012
From: AGRESTI, JEREMY
To: AMYRIS, INC.
Reel/Frame 028008/0857 →